R668-EE-1774: A PHASE 3, RANDOMIZED, 3-PART STUDY TO INVESTIGATE THEEFFICACY AND SAFETY OF DUPILUMAB IN ADULT ANDADOLESCENT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS

Project: Research project

Project Details

StatusActive
Effective start/end date6/26/208/31/50

Funding

  • Regeneron Pharmaceuticals, Inc.